We specialize in the treatment of uterine fibroids, adenomyosis and other specialized diseases. We are the affiliated hospital of National Engineering Research Center of Ultrasound Medicine, and also the Haifu ® demonstration Hospital integrating clinical scientific research and teaching.

We were born for Haifu ®,  Research Center of Chongqing Minimally Invasive and Noninvasive Treatment of Benign Diseases of Uterus and Vulva Disease.

We are located at the foot of Zhaumushan Botanical Garden, Liangjiang New Area, Chongqing, in the fresh, clean, ecological nature. We advocate that "respect life from organs", the micro-non-invasive medical concept of "treatment minimizes harm to patients", the medical model of "treat diseases to the diseased", and help patients realize "my health, my call!"

Professor Wang Zhibiao led his team, after more than 30 years of originality, realized the medical dream of treating internal diseases from outside without operation or bleeding. Chongqing Haifu Hospital applies this micro-non-invasive medical concept and technology to the clinical practice of benign and malignant tumors. Big data and artificial intelligence technology of clinical treatment, ultrasonic and nuclear magnetic positioning and guidance, offer clearer images,more accurate treatment . More and more patients know and choose, and doctors at home and abroad grasp and spread it all over the world.

At present, patients from more than 20 countries have been treated, accounting for more than 50%. Among them, more than 70% were difficult cases. In Chongqing Haifu Hospital, an international focused ultrasound ablation clinical training base has been established. Thousands of medical staff from Germany, Britain, Spain, South Korea, Singapore and other countries have come here for standardized and systematic training.

Haifu ® Focused Ultrasound Ablation Surgery Indications:
Solid tumors such as pancreatic cancer, liver cancer, bone tumor, soft tissue sarcoma, sclerofibroma, and kidney cancer; Uterine fibroids, adenomyosis of uterus, mammary fibroma, etc. Endometriosis of abdominal wall, placenta implantation, etc.
SeapostarUltrasound Therapy Indications:
Hypochromatic diseases of the vulva (leukoplakia of the vulva, dystrophia of the vulva, non-neoplastic lesions of the vulva epithelium);
 Cervical high-risk HPV persistent infection, chronic cervicitis, moderate and severe cervical erosion, condyloma acuminatum.

Services:

GynecologyDepartment:
It is characterized by gynecological micro noninvasive treatment for uterine fibroids and adenomyosis.
Covers gynecological common diseases such as:
female reproductive system inflammation; Hypochromatic disease of vulva;
Cervical, vaginal and vulvar intraepithelial lesions;
Benign and malignant tumors of gynecology;
Gestational trophoblastic disease; Endometriosis;
Gynecological acute abdomen, such as ectopic pregnancy, luteal rupture bleeding; Malformation of female reproductive tract;
Pelvic floor dysfunction and genital organ injury diseases;
Abnormal development of female genitalia;
Reproductive endocrine diseases;
Family planning; Female infertility and so on.

Oncology Department:
To perform focused ultrasound ablation and comprehensive treatment for solid tumors such as pancreatic cancer, liver cancer, bone tumor, soft tissue sarcoma, sclerofibroma, kidney cancer, breast cancer and mammary fibroma.

Internal medicine:
Cardiovascular, urinary, respiratory, digestive and other diseases.

Platform & Qualification
Global Haifu® Focused Ultrasound Ablation SurgeryDiagnosis and Treatment Center for Complicated Cases

Global Haifu® Focused Ultrasound Ablation Surgery
Clinical Training Center

Global Haifu® Focused Ultrasound Ablation Surgery
Clinic Research Coordination Center

Chongqing Minimally Invasive and Noninvasive Treatment of Benign Diseases of Uterus The Research Center

Chongqing of Minimally Invasive and Non-invasive Treatment of Vulva Disease
The Research Center

National Engineering Research Center of Ultrasound Medicine
International Clinical Training Base

Noninvasive Ultrasound Treatment of Benign and Malignant Tumors
International Clinical Demonstration Base